AstraZeneca Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
22 Nov 23 | Buy€233,122 | Michel Demare | Individual | 2,000 | €116.61 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 431,947 | 0.0279% |
Public Companies | 737,191 | 0.0476% |
Private Companies | 2,380,526 | 0.154% |
State or Government | 2,733,890 | 0.176% |
General Public | 210,495,254 | 13.6% |
Institutions | 1,333,477,494 | 86% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
155,435,297 | €22.9b | 17.6% | 1.22% | |||
137,588,369 | €20.3b | 2.04% | 0.37% | |||
98,340,427 | €14.5b | 26% | 2.37% | |||
71,452,666 | €10.5b | 1.95% | 0.18% | |||
51,587,810 | €7.6b | 0% | 11.56% | |||
35,415,803 | €5.2b | -0.34% | 0.46% | |||
31,039,283 | €4.6b | -42.1% | 0.45% | |||
29,472,139 | €4.3b | -5.92% | 0.29% | |||
27,627,154 | €4.1b | 3.52% | 0.17% | |||
26,023,128 | €3.8b | -2.03% | 0.79% | |||
21,472,587 | €3.2b | -0.1% | 2.37% | |||
18,851,059 | €2.8b | -4.07% | 0.36% | |||
18,797,637 | €2.8b | 11.3% | 0.62% | |||
15,863,398 | €2.3b | -12.1% | 2.1% | |||
15,739,513 | €2.3b | -5.13% | 1.1% | |||
12,631,034 | €1.9b | 0.04% | 0.24% | |||
11,887,908 | €1.8b | -3.23% | 2.61% | |||
11,053,280 | €1.6b | -18.8% | 1.14% | |||
10,994,983 | €1.6b | -3.44% | 2.11% | |||
10,665,114 | €1.6b | 0.09% | 0.26% | |||
10,536,060 | €1.6b | -2.83% | 1.25% | |||
10,517,154 | €1.5b | 26.3% | 0.45% | |||
10,452,907 | €1.5b | 23% | 2.57% | |||
9,116,175 | €1.3b | -13.5% | 0.33% | |||
9,087,870 | €1.3b | 84.5% | 0.52% |